Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qiuqiao Mu

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Cancers|March 28, 2026
Response-Adapted Benefit of Postoperative Adjuvant Therapy Following Neoadjuvant Treatment in Resectable NSCLC: A Single-Center Retrospective Cohort StudyYanbo Wang, Weiran Zhang, Xin Wang, et al.
Frontiers in Oncology|September 26, 2025
Comprehensive prognostic model for immunotherapy in small cell lung cancer: a multi-center study integrating clinical and blood biomarkersQiuqiao Mu, Yuhao Jing, Yun Ding, et al.
Frontiers in Immunology|August 11, 2025
Single-cell transcriptomic profiling reveals the heterogeneity of epithelial cells in lung adenocarcinoma lymph node metastasis and develops a prognostic signatureQiuqiao Mu, Han Zhang, Ying Shi, et al.
Lung Cancer (Amsterdam, Netherlands)|March 29, 2026
Risk stratification in stage I invasive non-mucinous lung adenocarcinoma based on high-risk histopathologic featuresKai Wang, Yun Ding, Zixiao Wang, et al.
Translational Lung Cancer Research|May 22, 2026
Prognostic nomogram for extensive-stage small-cell lung cancer in the immunotherapy era: a multicenter study of first-line platinum-etoposide with or without a PD-1/PD-L1 inhibitorYuhao Jing, Yifan Zhao, Zhenbao Zhou, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Cancers|March 28, 2026
Response-Adapted Benefit of Postoperative Adjuvant Therapy Following Neoadjuvant Treatment in Resectable NSCLC: A Single-Center Retrospective Cohort StudyYanbo Wang, Weiran Zhang, Xin Wang, et al.
Frontiers in Oncology|September 26, 2025
Comprehensive prognostic model for immunotherapy in small cell lung cancer: a multi-center study integrating clinical and blood biomarkersQiuqiao Mu, Yuhao Jing, Yun Ding, et al.
Frontiers in Immunology|August 11, 2025
Single-cell transcriptomic profiling reveals the heterogeneity of epithelial cells in lung adenocarcinoma lymph node metastasis and develops a prognostic signatureQiuqiao Mu, Han Zhang, Ying Shi, et al.
Lung Cancer (Amsterdam, Netherlands)|March 29, 2026
Risk stratification in stage I invasive non-mucinous lung adenocarcinoma based on high-risk histopathologic featuresKai Wang, Yun Ding, Zixiao Wang, et al.
Translational Lung Cancer Research|May 22, 2026
Prognostic nomogram for extensive-stage small-cell lung cancer in the immunotherapy era: a multicenter study of first-line platinum-etoposide with or without a PD-1/PD-L1 inhibitorYuhao Jing, Yifan Zhao, Zhenbao Zhou, et al.
Pageof 2